Showing 41-50 of 188 results for "".

• Almirall and Athenex Form Strategic Partnership for Treatment of AKs
  https://practicaldermatology.com/news/almirall-and-athenex-form-strategic-partnership-for-treatment-of-aks/2457957/
  Almirall, S.A and Athenex, Inc. recently formed a partnership to further develop and commercialize KX2-391 for the treatment of actinic keratosis (AK) and other skin conditions. Subject to the terms and conditions of the license agreement, Athenex will grant to Almirall an exclusive
• New Combo Therapy Beats Out Gold Standard Treatment For AKs
  https://practicaldermatology.com/news/new-combo-therapy-beats-out-gold-standard-treatment-for-aks/2458360/
  Combining a cream formulation of 5-fluorouracil with a synthetic form of vitamin D called calcipotriol may trigger a robust immune response against actinic keratosis, according to research out of rom Washington University School of Medicine in St. Louis and Harvard Medical School in Boston.
• FDA Approves New Combo Drug Plus Device Treatment for AKs
  https://practicaldermatology.com/news/fda-approves-new-combo-drug-plus-device-treatment-for-aks/2458568/
  The FDA approved Biofrontera AG’s combination topical prescription drug Ameluz (BF-200 ALA) and medical device BF-RhodoLED for photodynamic therapy (PDT) treatment of mild-to-moderate actinic keratosis (AK) on the face and scalp. The approval covers lesion-directed as well as field-directed
• FDA Warns of Severe Adverse Events with Application of Picato (ingenol mebutate) Gel; Requires Label Changes
  https://practicaldermatology.com/news/fda-warns-of-severe-adverse-events-with-application-of-picato-ingenol-mebutate-gel-requires-label-changes/2458878/
  The FDA released a Drug Safety Communication to warn about reports of severe allergic reactions and herpes zoster (shingles) associated with the use of Picato gel (ingenol mebutate), which is approved to treat actinic keratosis. The FDA said it also received reports of cases involving sev
• LEO Pharma Expands QualityCareTM Patient Support Program
  https://practicaldermatology.com/news/20131126-leo_pharma_expands_qualitycaretm_patient_support_program/2459403/
  LEO Pharma Inc. has expanded its QualityCareTM Program, a free and confidential patient support service for people affected by psoriasis or actinic keratosis. In addition to live nurse support through the www.qualitycarebyleo.com, the website also allows patients to choose relevant topics of interes

• New Products

  https://practicaldermatology.com/columns/new-products/new-products/20867/
  • Text

• Update on the Treatment of Actinic Keratoses

  https://practicaldermatology.com/topics/general-topics/update-on-the-treatment-of-actinic-keratoses/21630/
  From mainstay therapies to newly approved agents, treatment options for actinic keratoses are growing.
  • Text

• Reassessing Topical 5-Fluorouracil for AK Management

  https://practicaldermatology.com/topics/practice-management/reassessing-topical-5-fluorouracil-for-ak-management/21021/
  New research highlights the beneficial role of this therapeutic mainstay, alone and in combination with lesion-directed treatment.
  • Text

• Currents: Skin Cancer Update

  https://practicaldermatology.com/topics/skin-cancer-photoprotection/currents-skin-cancer-update/23259/
  • Text

• Pearls for Treating NMSC

  https://practicaldermatology.com/topics/skin-cancer-photoprotection/pearls-for-treating-nmsc/20775/
  Insights from DermTube.com
  • Text

• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• …
• 18
• 19
• Next